BHC
Income statement / Annual
Last year (2023), Bausch Health Companies Inc.'s total revenue was $8.76 B,
an increase of 7.79% from the previous year.
In 2023, Bausch Health Companies Inc.'s net income was -$592.00 M.
See Bausch Health Companies Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$8.76 B
|
$8.12 B
|
$8.43 B
|
$8.03 B
|
$8.60 B
|
$8.38 B
|
$8.72 B
|
$9.67 B
|
$10.50 B
|
$8.26 B
|
| Cost of Revenue |
$2.56 B |
$2.36 B |
$2.39 B |
$2.25 B |
$2.35 B |
$2.35 B |
$2.55 B |
$2.61 B |
$2.65 B |
$2.25 B |
| Gross Profit |
$6.20 B |
$5.76 B |
$6.04 B |
$5.78 B |
$6.25 B |
$6.03 B |
$6.18 B |
$7.06 B |
$7.85 B |
$6.01 B |
| Gross Profit Ratio |
0.71 |
0.71 |
0.72 |
0.72 |
0.73 |
0.72 |
0.71 |
0.73 |
0.75 |
0.73 |
| Research and Development
Expenses |
$604.00 M
|
$529.00 M
|
$465.00 M
|
$452.00 M
|
$471.00 M
|
$414.00 M
|
$366.00 M
|
$455.00 M
|
$582.80 M
|
$246.00 M
|
| General & Administrative
Expenses |
$2.27 B
|
$2.11 B
|
$2.11 B
|
$1.92 B
|
$2.01 B
|
$2.47 B
|
$2.58 B
|
$2.81 B
|
$2.70 B
|
$2.03 B
|
| Selling & Marketing
Expenses |
$625.00 M
|
$518.00 M
|
$515.00 M
|
$451.00 M
|
$544.00 M
|
$481.00 M
|
$462.00 M
|
$564.00 M
|
-$17.10 M
|
$435.00 M
|
| Selling, General &
Administrative Expenses |
$2.92 B
|
$2.63 B
|
$2.62 B
|
$2.37 B
|
$2.55 B
|
$2.47 B
|
$2.58 B
|
$2.81 B
|
$2.68 B
|
$2.03 B
|
| Other Expenses |
$1.71 B |
$1.25 B |
$1.75 B |
$1.65 B |
$3.31 B |
$21.00 M |
-$1.00 M |
-$73.00 M |
-$256.10 M |
$268.70 M |
| Operating Expenses |
$5.24 B |
$4.40 B |
$4.84 B |
$4.46 B |
$6.34 B |
$5.53 B |
$5.64 B |
$5.94 B |
$5.67 B |
$3.82 B |
| Cost And Expenses |
$7.79 B |
$6.77 B |
$7.23 B |
$6.71 B |
$8.69 B |
$7.88 B |
$8.19 B |
$8.55 B |
$8.31 B |
$6.08 B |
| Interest Income |
$26.00 M |
$14.00 M |
$7.00 M |
$13.00 M |
$12.00 M |
$11.00 M |
$12.00 M |
$8.00 M |
$3.30 M |
$5.00 M |
| Interest Expense |
$1.33 B |
$1.46 B |
$1.43 B |
$1.53 B |
$1.61 B |
$1.69 B |
$1.84 B |
$1.84 B |
$1.56 B |
$971.00 M |
| Depreciation &
Amortization |
$1.26 B
|
$1.34 B
|
$1.54 B
|
$1.92 B
|
$2.12 B
|
$2.68 B
|
$2.96 B
|
$2.83 B
|
$2.40 B
|
$1.55 B
|
| EBITDA |
$2.24 B
|
$2.62 B
|
$1.94 B
|
$2.55 B
|
$1.89 B
|
$332.15 M
|
$3.41 B
|
$2.24 B
|
$5.11 B
|
$3.91 B
|
| EBITDA Ratio |
0.26 |
0.32 |
0.31 |
0.31 |
0.21 |
0.38 |
0.39 |
0.56 |
0.48 |
0.5 |
| Operating Income Ratio
|
0.11
|
0.17
|
0.14
|
0.08
|
-0.01
|
-0.28
|
0.01
|
-0.06
|
0.15
|
0.25
|
| Total Other
Income/Expenses Net |
-$1.35 B
|
-$1.50 B
|
-$1.47 B
|
-$1.61 B
|
-$1.63 B
|
-$1.77 B
|
-$1.84 B
|
-$1.87 B
|
-$1.67 B
|
-$947.00 M
|
| Income Before Tax |
-$390.00 M |
-$129.00 M |
-$1.02 B |
-$934.00 M |
-$1.84 B |
-$4.15 B |
-$1.74 B |
-$2.44 B |
-$128.10 M |
$1.09 B |
| Income Before Tax Ratio
|
-0.04
|
-0.02
|
-0.12
|
-0.12
|
-0.21
|
-0.5
|
-0.2
|
-0.25
|
-0.01
|
0.13
|
| Income Tax Expense |
$221.00 M |
$83.00 M |
-$87.00 M |
-$375.00 M |
-$54.00 M |
-$10.00 M |
-$4.15 B |
-$27.00 M |
$134.20 M |
$180.40 M |
| Net Income |
-$592.00 M |
-$212.00 M |
-$937.00 M |
-$559.00 M |
-$1.78 B |
-$4.15 B |
$2.40 B |
-$2.41 B |
-$266.20 M |
$913.50 M |
| Net Income Ratio |
-0.07 |
-0.03 |
-0.11 |
-0.07 |
-0.21 |
-0.49 |
0.28 |
-0.25 |
-0.03 |
0.11 |
| EPS |
-1.62 |
-0.59 |
-2.61 |
-1.57 |
-5.06 |
-11.86 |
8.63 |
-6.94 |
-0.78 |
3.16 |
| EPS Diluted |
-1.62 |
-0.59 |
-2.61 |
-1.57 |
-5.06 |
-11.86 |
8.59 |
-6.94 |
-0.77 |
3.1 |
| Weighted Average Shares
Out |
$365.43 M
|
$362.00 M
|
$358.90 M
|
$355.00 M
|
$352.10 M
|
$349.87 M
|
$350.20 M
|
$347.12 M
|
$342.70 M
|
$335.40 M
|
| Weighted Average Shares
Out Diluted |
$364.90 M
|
$362.00 M
|
$358.90 M
|
$355.00 M
|
$352.10 M
|
$349.87 M
|
$351.80 M
|
$347.30 M
|
$347.30 M
|
$341.50 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
